28
Participants
Start Date
August 31, 2007
Primary Completion Date
January 31, 2010
Study Completion Date
November 30, 2011
RAD001
Oral pills taken daily in a 42-day cycle (6 weeks). Cycles will be repeated every 42 days
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
Dana-Farber Cancer Institute
OTHER
Beth Israel Deaconess Medical Center
OTHER
Novartis
INDUSTRY
Massachusetts General Hospital
OTHER